These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 14638377

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Raynaud disease].
    Pettersson T.
    Duodecim; 2005; 121(22):2411-9. PubMed ID: 16457072
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.
    Hirschl M, Hirschl K, Lenz M, Katzenschlager R, Hutter HP, Kundi M.
    Arthritis Rheum; 2006 Jun; 54(6):1974-81. PubMed ID: 16732585
    [Abstract] [Full Text] [Related]

  • 6. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W, Mastej K, Adamiec R.
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [Abstract] [Full Text] [Related]

  • 7. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al.
    Cutolo M, Pizzorni C, Sulli A.
    Arthritis Rheum; 2007 Jun; 56(6):2102-3; author reply 2103-4. PubMed ID: 17530659
    [No Abstract] [Full Text] [Related]

  • 8. Celiac disease in children, adolescents, and young adults with autoimmune thyroid disease.
    Sattar N, Lazare F, Kacer M, Aguayo-Figueroa L, Desikan V, Garcia M, Lane A, Chawla A, Wilson T.
    J Pediatr; 2011 Feb; 158(2):272-5.e1. PubMed ID: 20961564
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Update on current care guidelines. Celiac disease].
    Collin P, Julkunen R, Lehtola J, Kaukinen K, Mäki M, Rasmussen M, Reunala T, Savilahti E, Uusitupa M, Vuoristo M, Vuorio A.
    Duodecim; 2005 Feb; 121(24):2705-7. PubMed ID: 16454251
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Raynaud's phenomenon and anticentromere antibodies].
    Marquet Palomer R, Vilardell Tarrés M, Ordi Ros J.
    Med Clin (Barc); 1987 Nov 21; 89(17):721-4. PubMed ID: 3501051
    [No Abstract] [Full Text] [Related]

  • 13. Raynaud's phenomenon: clinical spectrum of 118 patients.
    De Angelis R, Del Medico P, Blasetti P, Cervini C.
    Clin Rheumatol; 2003 Oct 21; 22(4-5):279-84. PubMed ID: 14576990
    [Abstract] [Full Text] [Related]

  • 14. [Therapeutic (im)possibilities in Raynaud's phenomenon].
    Jager J.
    Ned Tijdschr Geneeskd; 1996 May 11; 140(19):1044. PubMed ID: 8684503
    [No Abstract] [Full Text] [Related]

  • 15. [The update findings on the celiac disease].
    Ansaldi-Balocco N, Dell'Olio D.
    Minerva Pediatr; 1992 Dec 11; 44(12):579-83. PubMed ID: 1301481
    [No Abstract] [Full Text] [Related]

  • 16. Antiendomysial antibodies in patients with end-stage heart failure.
    Prati D, Bardella MT, Peracchi M, Porretti L, Scalamogna M, Conte D.
    Am J Gastroenterol; 2002 Jan 11; 97(1):218-9. PubMed ID: 11808964
    [No Abstract] [Full Text] [Related]

  • 17. [Epidemiology of Raynaud's phenomenon in the general population].
    Maricq HR.
    Vasa Suppl; 1989 Jan 11; 27():15-7. PubMed ID: 2623492
    [No Abstract] [Full Text] [Related]

  • 18. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T, Komiyama T, Onozuka A, Miyata T, Shigematsu H.
    Eur J Vasc Endovasc Surg; 2004 Apr 11; 27(4):414-6. PubMed ID: 15015193
    [Abstract] [Full Text] [Related]

  • 19. Raynaud's phenomenon possibly induced by a compund drug of tegafur and uracil.
    Seishima M, Izumi T, Kanoh H.
    Eur J Dermatol; 2000 Apr 11; 10(1):55-8. PubMed ID: 10694301
    [Abstract] [Full Text] [Related]

  • 20. [Management of Raynaud's phenomenon].
    Lazareth I.
    Ann Dermatol Venereol; 2001 Apr 11; 128(4):553-6. PubMed ID: 11395659
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.